The Charcot foot in diabetes

Lee C. Rogers, Robert G. Frykberg, David G. Armstrong, Andrew J.M. Boulton, Michael Edmonds, Georges Ha Van, Agnes Hartemann, Frances Game, William Jeffcoate, Alexandra Jirkovska, Edward Jude, Stephan Morbach, William B. Morrison, Michael Pinzur, Dario Pitocco, Lee Sanders, Dane K. Wukich, Luigi Uccioli

Research output: Contribution to journalReview articlepeer-review

394 Scopus citations

Abstract

The diabetic Charcot foot syndrome is a serious and potentially limb-threatening lower-extremity complication of diabetes. First described in 1883, this enigmatic condition continues to challenge even the most experienced practitioners. Now considered an inflammatory syndrome, the diabetic Charcot foot is characterized by varying degrees of bone and joint disorganization secondary to underlying neuropathy, trauma, and perturbations of bone metabolism. An international task force of experts was convened by the American Diabetes Association and the American Podiatric Medical Association in January 2011 to summarize available evidence on the pathophysiology, natural history, presentations, and treatment recommendations for this entity.

Original languageEnglish (US)
Pages (from-to)2123-2129
Number of pages7
JournalDiabetes care
Volume34
Issue number9
DOIs
StatePublished - Sep 2011

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Fingerprint

Dive into the research topics of 'The Charcot foot in diabetes'. Together they form a unique fingerprint.

Cite this